These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15682577)

  • 21. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
    Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD
    J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin, a potent HMG-CoA reductase inhibitor, inhibits the proliferation of human and bovine endothelial cells in vitro.
    Sato I; Ma L; Ikeda M; Morita I; Murota S
    J Atheroscler Thromb; 1998; 4(3):102-6. PubMed ID: 9730140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
    Rydgren T; Sandler S
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1076-9. PubMed ID: 19150339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
    Conde K; Pineda G; Newton RS; Fernandez ML
    Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.
    Indolfi C; Cioppa A; Stabile E; Di Lorenzo E; Esposito G; Pisani A; Leccia A; Cavuto L; Stingone AM; Chieffo A; Capozzolo C; Chiariello M
    J Am Coll Cardiol; 2000 Jan; 35(1):214-21. PubMed ID: 10636283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
    Schlienger RG; Meier CR
    Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition.
    Calişkan S; Calişkan M; Kuralay F; Onvural B
    Res Exp Med (Berl); 2000 Feb; 199(4):189-94. PubMed ID: 10743676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel anabolic agent: a simvastatin analogue without HMG-CoA reductase inhibitory activity.
    Hsieh KC; Kao CL; Feng CW; Wen ZH; Chang HF; Chuang SC; Wang GJ; Ho ML; Wu SM; Chang JK; Chen HT
    Org Lett; 2014 Sep; 16(17):4376-9. PubMed ID: 25115530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on sterol absorption in hypercholesterolemic subjects.
    Ntanios FY; Jones PJ; Frohlich JJ
    Metabolism; 1999 Jan; 48(1):68-73. PubMed ID: 9920147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
    Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.
    Llorente-Cortés V; Martínez-González J; Badimon L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):738-46. PubMed ID: 9598832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats.
    Giusti-Paiva A; Martinez MR; Felix JV; da Rocha MJ; Carnio EC; Elias LL; Antunes-Rodrigues J
    Shock; 2004 Mar; 21(3):271-5. PubMed ID: 14770041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of statins on bone mineral density and bone histomorphometry in rodents.
    Maritz FJ; Conradie MM; Hulley PA; Gopal R; Hough S
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1636-41. PubMed ID: 11597938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats.
    Du Z; Chen J; Yan F; Xiao Y
    Clin Oral Implants Res; 2009 Feb; 20(2):145-50. PubMed ID: 19077150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells.
    Nogaki F; Muso E; Yashiro M; Kasuno K; Kamata T; Ono T; Sasayama S
    Kidney Int Suppl; 1999 Jul; 71():S198-201. PubMed ID: 10412775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin.
    Bergstrom JD; Bostedor RG; Rew DJ; Geissler WM; Wright SD; Chao YS
    Biochim Biophys Acta; 1998 Jan; 1389(3):213-21. PubMed ID: 9512650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase does not inhibit the platelet procoagulant response.
    Lindhout T; Wielders S; Hamulyak K; Bevers E; ten Cate H
    J Thromb Haemost; 2008 Aug; 6(8):1424-6. PubMed ID: 18485079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.